David M. Gershenson

34.1k citations
406 papers · 21.6k indexed · 3 hit papers · h-index 76
Topics
Ovarian cancer diagnosis and treatment (281 papers)Endometrial and Cervical Cancer Treatments (100 papers)Intraperitoneal and Appendiceal Malignancies (59 papers)

In The Last Decade

David M. Gershenson

398 papers receiving 21.1k citations

Hit Papers

Pelvic Radiation with Concurrent Chemotherapy Compared wi...199920262008201719992004200650010001.5k

Peers

David M. Gershenson
Comparison fields: 5 of 151
  • Reproductive Medicine 12.0k
  • Obstetrics and Gynecology 8.2k
  • Surgery 5.9k
  • Oncology 5.2k
  • Molecular Biology 4.2k
Replace David G. Mutch with:
David G. Mutch United States
Robert A. Soslow United States
Nicoletta Colombo Italy
Frédéric Amant Belgium
Richard R. Barakat United States
Karen H. Lu United States
Robert A. Burger United States
Gunnar B. Kristensen Norway
Thomas J. Herzog United States
Andreas du Bois Germany
David M. Gershenson relative to David G. Mutch United States David G. Mutch's profile →
Citations per field
00.5×1.7×
David G. Mutch · 1×
Citations per year

Countries citing papers authored by David M. Gershenson

Since Specialization
Citations

This map shows the geographic impact of David M. Gershenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Gershenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Gershenson more than expected).

Fields of papers citing papers by David M. Gershenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Gershenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Gershenson. The network helps show where David M. Gershenson may publish in the future.

Co-authorship network of co-authors of David M. Gershenson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Gershenson. A scholar is included among the top collaborators of David M. Gershenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Gershenson. David M. Gershenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 5
4 8
5 7
6 113
7 3
8 62
9 1
10 8
11 201
12 69
13 43
14 113
15 78
16 127
17 238
18
Why American women are not receiving state-of-the-art gynecologic cancer care.
15
19
Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals.
40
20
Clinical management of borderline ovarian tumors
2

About David M. Gershenson

David M. Gershenson is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 406 papers that have together received 21.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (281 papers), Endometrial and Cervical Cancer Treatments (100 papers) and Intraperitoneal and Appendiceal Malignancies (59 papers). The work is most often cited by research in Reproductive Medicine (12.0k citations), Obstetrics and Gynecology (8.2k citations) and Oncology (5.2k citations). David M. Gershenson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Karen H. Lu, Mitchell Morris, Elvio G. Silva, Thomas W. Burke, Michael T. Deavers, Charlotte C. Sun, Anaís Malpica, Charles Levenback, Patricia J. Eifel and David G. Mutch. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026